Impact of pre-diagnosis depressive symptoms and health-related quality of life on treatment choice for ductal carcinoma in situ and stage I breast cancer in older women
- 8 November 2018
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 173 (3) , 709-717
Abstract
To examine whether pre-diagnosis patient-reported health-related quality of life (HRQOL) and depressive symptoms are associated with local treatment for older women with ductal carcinoma in situ (DCIS) and stage I breast cancer (BC).Keywords
This publication has 59 references indexed in Scilit:
- Measuring decision quality: psychometric evaluation of a new instrument for breast cancer surgeryBMC Medical Informatics and Decision Making, 2012
- Assessing the Impact of a Cooperative Group Trial on Breast Cancer Care in the Medicare PopulationJournal of Clinical Oncology, 2012
- Prevalence of depression among older Americans: the Aging, Demographics and Memory StudyInternational Psychogeriatrics, 2009
- Practice Guideline for the Breast Conservation Therapy in the Management of Invasive Breast CarcinomaJournal of the American College of Surgeons, 2007
- Decision Aids and Breast Cancer: Do They Influence Choice for Surgery and Knowledge of Treatment Options?Journal of Clinical Oncology, 2007
- Discrimination in health care against people with mental illnessInternational Review of Psychiatry, 2007
- Factors associated with surgical options for breast carcinomaCancer, 2006
- Practical Geriatrics: Depression, Cognition, and Anxiety Among Postmenopausal Women With Breast CancerPsychiatric Services, 2005
- Depression as a Prognostic Factor for Breast Cancer MortalityPsychosomatics, 2003
- Patients with metastatic breast cancerInternational Journal of Rehabilitation Research, 1999